NYSE:BIO

Bio-rad Laboratories Stock Forecast

etoro logo Buy BIO
*Your capital is at risk
$354.54
+2.07 (+0.587%)
At Close: Aug 10, 2026

Should you buy BIO stock?

Last updated:

Based on market data through , StockInvest.us rates Bio-Rad Laboratories Inc (BIO) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is a downgrade from Strong Buy in the previous daily evaluation.

  • Hold signal since
  • Price since signal Up 17.80%
  • 3-month trend forecast Up 20.17%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of BIO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BIO to Watchlist?
Some Reasons Why To Add BIO:
  • Beat earnings estimates in all of the last 4 quarters
  • Excellent financial health (Piotroski 7/9)
  • Low bankruptcy risk (Altman Z-Score: 3.57)
PDF

Bio-Rad Laboratories Inc stock downgraded to Hold/Accumulate
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 16, 2026 Gain 17.80%

The Bio-Rad Laboratories Inc stock price gained 0.587% on the last trading day (Monday, 10th Aug 2026), rising from $352.47 to $354.54. During the last trading day the stock fluctuated 2.31% from a day low at $347.83 to a day high of $355.85. The price has been going up and down for this period, and there has been a 12.05% gain for the last 2 weeks. Volume fell on the last day by -107 thousand shares and in total, 160 thousand shares were bought and sold for approximately $56.85 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.17% during the next 3 months and, with a 90% probability hold a price between $364.34 and $442.26 at the end of this 3-month period.

BIO Signals & Forecast

The Bio-Rad Laboratories Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $341.48 and $308.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 23, 2026, and so far it has risen 31.16%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Bio-Rad Laboratories Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $318.22 and $281.82. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Bio-Rad Laboratories Inc finds support just below today's level at $318.22. If this is broken, then the next support from accumulated volume will be at $281.82 and $281.05.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $8.02 between high and low, or 2.31%. For the last week, the stock has had daily average volatility of 4.03%.

Our recommended stop-loss: $344.40 (-2.86%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 82 and this increases the risk substantially. There is a buy signal from a pivot bottom found 33 days ago.)

Trading Expectations (BIO) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Bio-Rad Laboratories Inc to open at $352.74, and during the day (based on 14 day Average True Range), to move between $348.80 and $360.28, which gives a possible trading interval of +/-$11.47 (+/-3.29%) up or down from last closing price. If Bio-Rad Laboratories Inc takes out the full calculated possible swing range there will be an estimated 3.29% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $318.22, some $36.32 (10.24%) from the current price of $354.54, our system finds the risk reward attractive.

Is Bio-Rad Laboratories Inc stock A Buy?

Bio-Rad Laboratories Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $352.74 ( 0.508%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BIO Performance

Trading levels for BIO

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 360.76 1.75%
R2 357.70 0.89%
R1 355.80 0.356%
Price 354.54
S1 349.68 -1.37%
S2 347.78 -1.91%
S3 344.72 -2.77%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 354.54
S1 318.22 -10.24%
S2 281.82 -20.51%
S3 281.05 -20.73%

FAQ

What is the symbol for Bio-Rad Laboratories Inc Stock and on which exchange is it traded?
The symbol for Bio-Rad Laboratories Inc is BIO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Bio-Rad Laboratories Inc Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Bio-Rad Laboratories Inc (BIO) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is a downgrade from Strong Buy in the previous daily evaluation. Since the Hold signal began on Jul 16, 2026, the price has risen 17.80%. The current 3-month trend forecast projects a rise of 20.17%.

How to buy Bio-Rad Laboratories Inc Stock?
Bio-Rad Laboratories Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bio-Rad Laboratories Inc Stock.

What's the current price of Bio-Rad Laboratories Inc Stock?
As of the end of day on the Aug 10, 2026, the price of an Bio-Rad Laboratories Inc (BIO) share was $354.54.

What is the 52-week high and low for Bio-Rad Laboratories Inc Stock?
The 52-week high for Bio-Rad Laboratories Inc Stock is $355.85 and the 52-week low is $236.73.

What is the market capitalization of Bio-Rad Laboratories Inc Stock?
As of the Aug 10, 2026, the market capitalization of Bio-Rad Laboratories Inc is 9.543B.

When is the next earnings date for Bio-Rad Laboratories Inc?
The upcoming earnings date for Bio-Rad Laboratories Inc is Oct 29, 2026.
Click to get the best stock tips daily for free!
ABOUT BIO-RAD LABORATORIES INC
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, ...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE